APO Research
Talk to an analyst

APO RESEARCH · REPORT

Respiratory Drug

Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.

Selected research

Industry Growth & Trends

Global Respiratory Drug Industry Growth and Trends Forecast to 2032

28 December 2025106 pages

Choose your research edition.

Industry ResearchRespiratory Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Respiratory Drug Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Respiratory Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Respiratory Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Respiratory Drug Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.

The classification of Respiratory Drug includes Inhalable & Nasal Spray, Oral and Others, and the proportion of Inhalable & Nasal Spray in 2019 is about 68.82%.

Respiratory Drug widely sold through Hospital and Drugs Store. The most proportion of Respiratory Drug sold through Drugs Store, and the proportion in 2019 is 58.28%.

Read the full market overview

North America is the largest consumption place, with a consumption market share nearly 35.24% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 28.58%. Moreover, the Asian market is expected to register the highest CAGR during the forecast period.

Market competition is intense. GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, etc. are the leaders of the industry.

Report Scope

This report provides a structured, data-driven view of the global Respiratory Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Respiratory Drug market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Respiratory Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Respiratory Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Respiratory Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Respiratory Drug Market by Company

GSK

AstraZeneca

Boehringer Ingelheim

Vertex

Roche

Novartis

Teva

Chiesi

Mylan

Sumitomo Dainippon

Merck

Beximco

Respiratory Drug Segment by Type

Inhalable & Nasal Spray

Oral

Others

Respiratory Drug Segment by Application

Hospital

Drugs Store

Respiratory Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Respiratory Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Respiratory Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Respiratory Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Respiratory Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Respiratory Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Inhalable & Nasal Spray Table 2. Major Company of Oral Table 3. Major Company of Others Table 4. Global Respiratory Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Respiratory Drug Sales by Type (2021-2026) & (M Units) Table 6. Global Respiratory Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Respiratory Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Respiratory Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Respiratory Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Respiratory Drug Sales by Type (2027-2032) & (M Units) Table 11. Global Respiratory Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Respiratory Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Respiratory Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Respiratory Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Respiratory Drug Sales by Type (2021-2026) & (M Units) Table 16. North America Respiratory Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Respiratory Drug Sales by Type (2021-2026) & (M Units) Table 18. Europe Respiratory Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Respiratory Drug Sales by Type (2021-2026) & (M Units) Table 20. Asia-Pacific Respiratory Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Respiratory Drug Sales by Type (2021-2026) & (M Units) Table 22. Latin America Respiratory Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Respiratory Drug Sales by Type (2021-2026) & (M Units) Table 24. Middle East and Africa Respiratory Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Respiratory Drug Industry Trends Table 26. Respiratory Drug Industry Drivers Table 27. Respiratory Drug Industry Opportunities and Challenges Table 28. Respiratory Drug Industry Restraints Table 29. Global Respiratory Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Respiratory Drug Revenue Market Share by Company (2021-2026) Table 31. Global Respiratory Drug Sales by Company (2021-2026) & (M Units) Table 32. Global Respiratory Drug Sales Share by Company (2021-2026) Table 33. Global Respiratory Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Respiratory Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Respiratory Drug Major Company Production Sites and Headquarters Table 36. Global Respiratory Drug Company, Product Type & Application Table 37. Global Respiratory Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Respiratory Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Respiratory Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Respiratory Drug Sales by Region (2021-2026) & (M Units) Table 42. Global Respiratory Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Respiratory Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Respiratory Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Respiratory Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Respiratory Drug Sales by Region (2027-2032) & (M Units) Table 47. Global Respiratory Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Respiratory Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Respiratory Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Respiratory Drug Sales (M Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Respiratory Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Respiratory Drug Sales by Application (2021-2026) & (M Units) Table 53. Global Respiratory Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Respiratory Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Respiratory Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Respiratory Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Respiratory Drug Sales by Application (2027-2032) & (M Units) Table 58. Global Respiratory Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Respiratory Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Respiratory Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Respiratory Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Respiratory Drug Sales by Application (2021-2026) & (M Units) Table 63. North America Respiratory Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Respiratory Drug Sales by Application (2021-2026) & (M Units) Table 65. Europe Respiratory Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Respiratory Drug Sales by Application (2021-2026) & (M Units) Table 67. Asia-Pacific Respiratory Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Respiratory Drug Sales by Application (2021-2026) & (M Units) Table 69. Latin America Respiratory Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Respiratory Drug Sales by Application (2021-2026) & (M Units) Table 71. Middle East and Africa Respiratory Drug Sales by Application (2021-2026) & (US$ Million) Table 72. GSK Company Information Table 73. GSK Business Overview Table 74. GSK Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. GSK Respiratory Drug Product Portfolio Table 76. GSK Recent Development Table 77. AstraZeneca Company Information Table 78. AstraZeneca Business Overview Table 79. AstraZeneca Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. AstraZeneca Respiratory Drug Product Portfolio Table 81. AstraZeneca Recent Development Table 82. Boehringer Ingelheim Company Information Table 83. Boehringer Ingelheim Business Overview Table 84. Boehringer Ingelheim Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Boehringer Ingelheim Respiratory Drug Product Portfolio Table 86. Boehringer Ingelheim Recent Development Table 87. Vertex Company Information Table 88. Vertex Business Overview Table 89. Vertex Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Vertex Respiratory Drug Product Portfolio Table 91. Vertex Recent Development Table 92. Roche Company Information Table 93. Roche Business Overview Table 94. Roche Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Roche Respiratory Drug Product Portfolio Table 96. Roche Recent Development Table 97. Novartis Company Information Table 98. Novartis Business Overview Table 99. Novartis Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Novartis Respiratory Drug Product Portfolio Table 101. Novartis Recent Development Table 102. Teva Company Information Table 103. Teva Business Overview Table 104. Teva Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Teva Respiratory Drug Product Portfolio Table 106. Teva Recent Development Table 107. Chiesi Company Information Table 108. Chiesi Business Overview Table 109. Chiesi Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Chiesi Respiratory Drug Product Portfolio Table 111. Chiesi Recent Development Table 112. Mylan Company Information Table 113. Mylan Business Overview Table 114. Mylan Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Mylan Respiratory Drug Product Portfolio Table 116. Mylan Recent Development Table 117. Sumitomo Dainippon Company Information Table 118. Sumitomo Dainippon Business Overview Table 119. Sumitomo Dainippon Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Sumitomo Dainippon Respiratory Drug Product Portfolio Table 121. Sumitomo Dainippon Recent Development Table 122. Merck Company Information Table 123. Merck Business Overview Table 124. Merck Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Merck Respiratory Drug Product Portfolio Table 126. Merck Recent Development Table 127. Beximco Company Information Table 128. Beximco Business Overview Table 129. Beximco Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Beximco Respiratory Drug Product Portfolio Table 131. Beximco Recent Development Table 132. North America Respiratory Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 133. North America Respiratory Drug Sales by Country (2021-2026) & (M Units) Table 134. North America Respiratory Drug Sales Market Share by Country (2021-2026) Table 135. North America Respiratory Drug Sales Forecast by Country (2027-2032) & (M Units) Table 136. North America Respiratory Drug Sales Market Share Forecast by Country (2027-2032) Table 137. North America Respiratory Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Respiratory Drug Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Respiratory Drug Market Share by Country (2021-2026) Table 140. North America Respiratory Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Respiratory Drug Market Share Forecast by Country (2027-2032) Table 142. Europe Respiratory Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 143. Europe Respiratory Drug Sales by Country (2021-2026) & (M Units) Table 144. Europe Respiratory Drug Sales Market Share by Country (2021-2026) Table 145. Europe Respiratory Drug Sales Forecast by Country (2027-2032) & (M Units) Table 146. Europe Respiratory Drug Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Respiratory Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Respiratory Drug Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Respiratory Drug Market Share by Country (2021-2026) Table 150. Europe Respiratory Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Respiratory Drug Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Respiratory Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Respiratory Drug Sales by Country (2021-2026) & (M Units) Table 154. Asia-Pacific Respiratory Drug Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Respiratory Drug Sales Forecast by Country (2027-2032) & (M Units) Table 156. Asia-Pacific Respiratory Drug Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Respiratory Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Respiratory Drug Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Respiratory Drug Market Share by Country (2021-2026) Table 160. Asia-Pacific Respiratory Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Respiratory Drug Market Share Forecast by Country (2027-2032) Table 162. Latin America Respiratory Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 163. Latin America Respiratory Drug Sales by Country (2021-2026) & (M Units) Table 164. Latin America Respiratory Drug Sales Market Share by Country (2021-2026) Table 165. Latin America Respiratory Drug Sales Forecast by Country (2027-2032) & (M Units) Table 166. Latin America Respiratory Drug Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Respiratory Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Respiratory Drug Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Respiratory Drug Market Share by Country (2021-2026) Table 170. Latin America Respiratory Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Respiratory Drug Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Respiratory Drug Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Respiratory Drug Sales by Country (2021-2026) & (M Units) Table 174. Middle East and Africa Respiratory Drug Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Respiratory Drug Sales Forecast by Country (2027-2032) & (M Units) Table 176. Middle East and Africa Respiratory Drug Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Respiratory Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Respiratory Drug Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Respiratory Drug Market Share by Country (2021-2026) Table 180. Middle East and Africa Respiratory Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Respiratory Drug Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Respiratory Drug Distributors List Table 185. Respiratory Drug Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Respiratory Drug Image Figure 2. Global Respiratory Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Respiratory Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Respiratory Drug Sales (2021-2032) & (M Units) Figure 5. Inhalable & Nasal Spray Image Figure 6. Global Inhalable & Nasal Spray Sales YoY Growth (2021-2032) & (M Units) Figure 7. Oral Image Figure 8. Global Oral Sales YoY Growth (2021-2032) & (M Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (M Units) Figure 11. Global Respiratory Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Respiratory Drug Market Share by Type 2025 VS 2032 Figure 13. North America Respiratory Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Respiratory Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Respiratory Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Respiratory Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Respiratory Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Respiratory Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Respiratory Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Respiratory Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Respiratory Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Respiratory Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Respiratory Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (M Units) Figure 27. Drugs Store Image Figure 28. Global Drugs Store Sales YoY Growth (2021-2032) & (M Units) Figure 29. Global Respiratory Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Respiratory Drug Market Share by Application 2025 VS 2032 Figure 31. North America Respiratory Drug Sales Market Share in Volume by Application in 2025 Figure 32. North America Respiratory Drug Sales Market Share in Value by Application in 2025 Figure 33. Europe Respiratory Drug Sales Market Share in Volume by Application in 2025 Figure 34. Europe Respiratory Drug Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Respiratory Drug Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Respiratory Drug Sales Market Share in Value by Application in 2025 Figure 37. Latin America Respiratory Drug Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Respiratory Drug Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Respiratory Drug Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Respiratory Drug Sales Market Share in Value by Application in 2025 Figure 41. North America Respiratory Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 42. North America Respiratory Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Respiratory Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Respiratory Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Respiratory Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 46. Europe Respiratory Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Respiratory Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Respiratory Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Respiratory Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 50. Asia-Pacific Respiratory Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Respiratory Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Respiratory Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Respiratory Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. Latin America Respiratory Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Respiratory Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Respiratory Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Respiratory Drug Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Middle East and Africa Respiratory Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Respiratory Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Respiratory Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Respiratory Drug Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Respiratory Drug Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Inhalable & Nasal Spray
  • Oral
  • Others
Applications
  • Hospital
  • Drugs Store
Companies covered
  • GSK
  • AstraZeneca
  • Boehringer Ingelheim
  • Vertex
  • Roche
  • Novartis
  • Teva
  • Chiesi
  • Mylan
  • Sumitomo Dainippon
  • Merck
  • Beximco

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Respiratory Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Respiratory Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Respiratory Drug Market by Type
  6. 1.3.1 Inhalable & Nasal Spray
  7. 1.3.2 Oral
  8. 1.3.3 Others
  9. 1.4 Global Respiratory Drug Market Size by Type
  10. 1.4.1 Global Respiratory Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Respiratory Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Respiratory Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Respiratory Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Respiratory Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Respiratory Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Respiratory Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Respiratory Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Respiratory Drug Industry Trends
  2. 2.2 Respiratory Drug Industry Drivers
  3. 2.3 Respiratory Drug Industry Opportunities and Challenges
  4. 2.4 Respiratory Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Respiratory Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Respiratory Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Respiratory Drug Price (2021-2026)
  4. 3.4 Global Respiratory Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Respiratory Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Respiratory Drug Company, Product Type & Application
  7. 3.7 Global Respiratory Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Respiratory Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Respiratory Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Respiratory Drug Tier 1, Tier 2, and Tier 3
4 Respiratory Drug Regional Status and Outlook
  1. 4.1 Global Respiratory Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Respiratory Drug Historic Market Size by Region
  3. 4.2.1 Global Respiratory Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Respiratory Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Respiratory Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Respiratory Drug Forecasted Market Size by Region
  7. 4.3.1 Global Respiratory Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Respiratory Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Respiratory Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Respiratory Drug by Application
  1. 5.1 Respiratory Drug Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Store
  4. 5.2 Global Respiratory Drug Market Size by Application
  5. 5.2.1 Global Respiratory Drug Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Respiratory Drug Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Respiratory Drug Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Respiratory Drug Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Respiratory Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Respiratory Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Respiratory Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Respiratory Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Respiratory Drug Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 AstraZeneca
  8. 6.2.1 AstraZeneca Company Information
  9. 6.2.2 AstraZeneca Business Overview
  10. 6.2.3 AstraZeneca Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 AstraZeneca Respiratory Drug Product Portfolio
  12. 6.2.5 AstraZeneca Recent Developments
  13. 6.3 Boehringer Ingelheim
  14. 6.3.1 Boehringer Ingelheim Company Information
  15. 6.3.2 Boehringer Ingelheim Business Overview
  16. 6.3.3 Boehringer Ingelheim Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Boehringer Ingelheim Respiratory Drug Product Portfolio
  18. 6.3.5 Boehringer Ingelheim Recent Developments
  19. 6.4 Vertex
  20. 6.4.1 Vertex Company Information
  21. 6.4.2 Vertex Business Overview
  22. 6.4.3 Vertex Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Vertex Respiratory Drug Product Portfolio
  24. 6.4.5 Vertex Recent Developments
  25. 6.5 Roche
  26. 6.5.1 Roche Company Information
  27. 6.5.2 Roche Business Overview
  28. 6.5.3 Roche Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Roche Respiratory Drug Product Portfolio
  30. 6.5.5 Roche Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Respiratory Drug Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Teva
  38. 6.7.1 Teva Company Information
  39. 6.7.2 Teva Business Overview
  40. 6.7.3 Teva Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Teva Respiratory Drug Product Portfolio
  42. 6.7.5 Teva Recent Developments
  43. 6.8 Chiesi
  44. 6.8.1 Chiesi Company Information
  45. 6.8.2 Chiesi Business Overview
  46. 6.8.3 Chiesi Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Chiesi Respiratory Drug Product Portfolio
  48. 6.8.5 Chiesi Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan Respiratory Drug Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Sumitomo Dainippon
  56. 6.10.1 Sumitomo Dainippon Company Information
  57. 6.10.2 Sumitomo Dainippon Business Overview
  58. 6.10.3 Sumitomo Dainippon Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sumitomo Dainippon Respiratory Drug Product Portfolio
  60. 6.10.5 Sumitomo Dainippon Recent Developments
  61. 6.11 Merck
  62. 6.11.1 Merck Company Information
  63. 6.11.2 Merck Business Overview
  64. 6.11.3 Merck Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Merck Respiratory Drug Product Portfolio
  66. 6.11.5 Merck Recent Developments
  67. 6.12 Beximco
  68. 6.12.1 Beximco Company Information
  69. 6.12.2 Beximco Business Overview
  70. 6.12.3 Beximco Respiratory Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Beximco Respiratory Drug Product Portfolio
  72. 6.12.5 Beximco Recent Developments
7 North America by Country
  1. 7.1 North America Respiratory Drug Sales by Country
  2. 7.1.1 North America Respiratory Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Respiratory Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Respiratory Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Respiratory Drug Market Size by Country
  6. 7.2.1 North America Respiratory Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Respiratory Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Respiratory Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Respiratory Drug Sales by Country
  2. 8.1.1 Europe Respiratory Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Respiratory Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Respiratory Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Respiratory Drug Market Size by Country
  6. 8.2.1 Europe Respiratory Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Respiratory Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Respiratory Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Respiratory Drug Sales by Country
  2. 9.1.1 Asia-Pacific Respiratory Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Respiratory Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Respiratory Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Respiratory Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Respiratory Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Respiratory Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Respiratory Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Respiratory Drug Sales by Country
  2. 10.1.1 South America Respiratory Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Respiratory Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Respiratory Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Respiratory Drug Market Size by Country
  6. 10.2.1 South America Respiratory Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Respiratory Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Respiratory Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Respiratory Drug Sales by Country
  2. 11.1.1 Middle East and Africa Respiratory Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Respiratory Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Respiratory Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Respiratory Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Respiratory Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Respiratory Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Respiratory Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Respiratory Drug Value Chain Analysis
  2. 12.1.1 Respiratory Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Respiratory Drug Production Mode & Process
  7. 12.2 Respiratory Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Respiratory Drug Distributors
  10. 12.2.3 Respiratory Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst